Fluorometric measurement of 5-aminolevulinic acid in serum

Clinica Chimica Acta

Volumn 347, Issue 1-2, 2004, Pages 183-188

  Lee, Chul ^a   Qiao, Xian ^a   Goeger, Douglas E ^a   Anderson, Karl E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

5 Aminolevulinic acid (ALA); Hantzsch reaction; HPLC method; Lead poisoning; Porphyria; Porphyrin; Spectrofluorometry

Indexed keywords

ACETYLACETONE; AMINO ACID; AMINO ACID DERIVATIVE; AMINOLEVULINIC ACID; FORMALDEHYDE;

ACUTE INTERMITTENT PORPHYRIA; ADDITION REACTION; ADULT; AGED; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CATION EXCHANGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LEAD POISONING; MALE; PORPHYRIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION ANALYSIS; REGRESSION ANALYSIS; SPECTROFLUOROMETRY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AMINOLEVULINIC ACID; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPROPORPHYRIA, HEREDITARY; FEMALE; HUMANS; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; PORPHYRIA, ACUTE INTERMITTENT; REFERENCE STANDARDS; SPECTROMETRY, FLUORESCENCE;

EID: 4143059224     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.04.015     Document Type: Article

References (22)

1. Anderson K.E., Sassa S., Bishop D.F., Desnick R.J. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8th ed. The metabolic basis of inherited disease. vol. 1:2001;2991-3062 McGraw-Hill, New York
2. Thunell S., Harper P., Brock A., Petersen N.E. Porphyrins, porphyrin metabolism and porphyrias: II. Diagnosis and monitoring in the acute porphyrias. Scand J. Clin. Lab. Invest. 60(1):2000;541-560
3. Sithisarankul P., Cadorette M., Davoli C.T., Serwint J.R., Chisolm J.J., Strickland P.T. Plasma 5-aminolevulinic acid concentration and lead exposure in children. Environ. Res., Sect. A. 80(1):1999;41-49
4. Oishi H., Nomiyama H., Nomiyama K., Tomokuni K. Fluorometric HPLC determination of Δ-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J. Anal. Toxicol. 20(1):1996;106-110
5. Takebayashi T., Hosoda O.K., Hamaguchi S.T., Sakurai H. Evaluation of δ-aminolevulinic acid in blood of workers exposed to lead. Br. J. Ind. Med. 50(1):1993;49-54
6. Morita Y., Araki S., Sakai T., Araki T., Masuyama Y. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects. Ind. Health. 32(1):1994;85-96
7. Gorchein A., Webber R. Delta-aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects. Clin. Sci. 72(1):1987;103-112
8. Mustajoki P., Timonen K., Gorchein A., Seppalainen A.M., Matikainen E., Tenhunen R. Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms. Eur. J. Clin. Invest. 22(1):1992;407-411
9. Sun M.W., Stein E., Gruen F.W. A single column method for the determination of urinary δ-aminolevulinic acid. Clin. Chem. 15(1):1969;183-189
10. Tomokuni K., Ogata M. Simple method for determination of urinary δ-aminolevulinic acid as an index of lead exposure. Clin. Chem. 18(1):1972;1534-1536
11. Gorchein A. Determination of delta-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection. Biochem. J. 219(1):1984;883-889
12. Tomokuni K., Ichiba M., Hirai Y. HPLC micro-method for determining δ-aminolevulinic acid in plasma. Clin. Chem. 39(1):1993;169-170
13. Solberg H.E. Establishment and use of reference values. Burtis C.A., Ashwood E.R. Fundamentals of clinical chemistry. 2001;251-261 Saunders, Philadelphia
14. Tomokuni K., Ichiba M., Fujishiro K. Interrelation between urinary δ-aminolevulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead. Ind. Health. 31(1):1993;51-57
15. Bannon D.I., Murashchik C., Zapf C.R., Farfel M.R., Chisolm J.J. Jr. Graphite furnace atomic absorption spectroscopic measurement of blood lead in matrix-matched standards. Clin. Chem. 40(1):1994;1730-1734
16. Bonkowsky H.L., Sinclair P.R., Emery S., Sinclair J.F. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology. 30(1):1980;588-592
17. Rapeport W.G., Connell J.C., Thompson G.G., Moore M.R., Brodie M.J. Effect of carbamazepine on heme biosynthesis in man. Eur. J. Clin. Invest. 14(1):1984;107-110
18. McGuire G.M., Macphee G.J.A., Thompson G.G., Brodie M.J. Effect of sodium valproate on heme biosynthesis in man. Clin. Sci. 72(Suppl. 16):1987;23-24
19. Gorchein A., Webber R. Effect of anticonvulsant drugs on serum δ-aminolaevulinic acid levels in non-porphyric subjects. Br. J. Clin. Pharmacol. 24(1):1987;847-848
20. Mauzerall D., Granick S. The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J. Biol. Chem. 219(1):1956;435-446
21. Sun M.W., Stein E., Gruen F.W. A single column method for the determination of urinary δ-aminolevulinic acid. Clin. Chem. 15(1):1969;183-189
22. Costa C.A., Trivelato G.C., Pinto A.M.P., Bechara E.J.H. Correlation between plasma 5-aminolevulinic acid concentrations and indicators of oxidative stress in lead-exposed workers. Clin. Chem. 43(1):1997;1196-1202